AstraZeneca (OSTO:AZN) Cyclically Adjusted Book per Share: kr199.79 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:AZN AstraZeneca PLC OSTO:AZN
91 GF Score
Price kr1,650.00
GF Value kr1,757.83
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is AstraZeneca Cyclically Adjusted Book per Share?

AstraZeneca OSTO:AZN +0.09% 91 Cyclically Adjusted Book per Share is kr199.79 as of Mar. 2026. GuruFocus rates OSTO:AZN with a GF Score™ of 91/100 and a GF Value™ of kr1,757.83 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

AstraZeneca's adjusted book value per share for the three months ended in Mar. 2026 was kr284.370. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr199.79 for the trailing ten years ended in Mar. 2026.

During the past 12 months, AstraZeneca's average Cyclically Adjusted Book Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of AstraZeneca was 12.50% per year. The lowest was -0.90% per year. And the median was 5.70% per year.

As of today (2026-07-25), AstraZeneca's current stock price is kr1650.00. AstraZeneca's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr199.79. AstraZeneca's Cyclically Adjusted PB Ratio of today is 8.26.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 4.21. And the median was 7.91.


AstraZeneca  (OSTO:AZN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AstraZeneca's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1650.00/199.79
=8.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 4.21. And the median was 7.91.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


AstraZeneca Cyclically Adjusted Book per Share Related Terms


AstraZeneca Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for AstraZeneca's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca Cyclically Adjusted Book per Share Chart

AstraZeneca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 128.96 150.38 165.10 194.01 190.73

AstraZeneca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 186.04 194.29 191.63 190.73 199.79

OSTO:AZN vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Cyclically Adjusted PB Ratio falls into.


OSTO:AZN
91GF Score
AstraZeneca PLC OSTO:AZN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AstraZeneca Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AstraZeneca's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=284.37/140.8000*140.8000
=284.370

Current CPI (Mar. 2026) = 140.8000.

AstraZeneca Quarterly Data

Book Value per Share CPI Adj_Book
201606 88.820 101.000 123.820
201609 88.157 101.500 122.291
201612 108.092 102.200 148.917
201703 91.464 102.700 125.396
201706 93.602 103.500 127.335
201709 86.840 104.300 117.230
201712 99.155 105.000 132.962
201803 84.027 105.100 112.569
201806 87.860 105.900 116.815
201809 84.230 106.600 111.253
201812 88.861 107.100 116.822
201903 74.267 107.000 97.727
201906 97.171 107.900 126.800
201909 90.020 108.400 116.926
201912 94.364 108.500 122.456
202003 80.853 108.600 104.826
202006 86.821 108.800 112.357
202009 82.292 109.200 106.105
202012 99.529 109.400 128.096
202103 93.908 109.700 120.531
202106 100.264 111.400 126.725
202109 221.767 112.400 277.801
202112 230.367 114.700 282.787
202203 224.337 116.500 271.130
202206 232.706 120.500 271.909
202209 247.379 122.300 284.799
202212 248.013 125.300 278.693
202303 241.918 126.800 268.628
202306 259.813 129.400 282.702
202309 266.030 130.100 287.909
202312 259.014 130.500 279.457
202403 251.481 131.600 269.062
202406 267.284 133.000 282.959
202409 268.668 133.500 283.359
202412 289.035 135.100 301.230
202503 268.253 136.100 277.517
202506 275.434 138.400 280.210
202509 277.434 138.900 281.229
202512 291.655 139.900 293.531
202603 284.370 140.800 284.370

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr199.79 mean?
AstraZeneca (OSTO:AZN) has a Cyclically Adjusted Book per Share of kr199.79 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AstraZeneca and its competitors.
Is AstraZeneca's Cyclically Adjusted Book per Share too high?
AstraZeneca's current Cyclically Adjusted Book per Share is kr199.79. Overall, AstraZeneca has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca's Cyclically Adjusted Book per Share compare to LLY and JNJ?
AstraZeneca's Cyclically Adjusted Book per Share of kr199.79 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AstraZeneca and its competitors. AstraZeneca's current Cyclically Adjusted Book per Share is kr199.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca stock overvalued right now?
Based on GuruFocus' analysis, AstraZeneca (OSTO:AZN) is currently considered Fairly Valued. The stock's GF Value™ is kr1,757.83, compared to a current price of kr1,650.00 — trading 6.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is kr199.79. AstraZeneca's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For AstraZeneca (OSTO:AZN), the current Cyclically Adjusted Book per Share is kr199.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AstraZeneca (OSTO:AZN) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be undervalued. The current stock price of kr1,650.00 is trading 6.1% below its estimated GF Value™ of kr1,757.83. GuruFocus considers AstraZeneca to be Fairly Valued.

Key valuation signals for OSTO:AZN:

  • Cyclically Adjusted Book per Share: kr199.79
  • GF Value™: kr1,757.83 vs. price of kr1,650.00 (6.1% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the OSTO:AZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
91GF Score

Get the complete analysis for OSTO:AZN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1,650.00
Price
kr1,757.83
GF Value